Related Experiment Videos
Clinical evaluation of mature teratomas containing malignant elements
1Department of Obstetrics and Gynecology, Osaka City University Medical School, Osaka 545-8585, Japan.
Oncology Reports
|April 18, 2000
Summary
Mature ovarian teratoma with malignant elements (MOTME) can be preoperatively diagnosed using imaging and tumor markers. Early-stage MOTME offers a better survival prognosis, while advanced stages have a poor outlook.
Area of Science:
- Gynecologic Oncology
- Pathology
- Radiology
Background:
- Mature ovarian teratomas are common germ cell tumors.
- Malignant transformation within mature teratomas is rare but clinically significant.
- Preoperative diagnosis of malignant elements in teratomas remains challenging.
Purpose of the Study:
- To investigate the clinical features and diagnostic possibilities of mature ovarian teratoma containing malignant elements (MOTME).
- To evaluate the effectiveness of preoperative diagnostic tools for MOTME.
Main Methods:
- Retrospective review of 5 MOTME cases diagnosed between 1982 and 1998.
- Analysis of patient demographics, clinical presentation, serum tumor marker levels (CA19-9, CA125, SCC, CEA), and diagnostic imaging findings.
- Correlation of preoperative findings with histopathological diagnoses and patient outcomes.
Main Results:
- MOTME represented 2.0% of all mature ovarian teratomas in the study period.
- Elevated serum tumor markers (CA19-9, CA125, SCC, CEA) were observed in all cases.
- Preoperative suspicion of malignancy was high, supported by imaging and tumor markers.
- Stage I squamous cell carcinoma and borderline malignancy cases survived.
- Two advanced-stage cases resulted in mortality within 8 months.
Conclusions:
- Preoperative diagnosis of MOTME is feasible using a combination of serum tumor markers and diagnostic imaging.
- Early detection and treatment of MOTME are crucial for improving patient survival.
- Advanced stage MOTME carries a poor prognosis, highlighting the need for timely intervention.